XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Convertible Notes Payable
Convertible Debt
Warrant Issued For Vessel Consideration
Common Stock
Common Stock
Convertible Notes Payable
Convertible Debt
Common Stock
Warrant Issued For Vessel Consideration
Additional paid-in Capital
Additional paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
[1]
Additional paid-in Capital
Convertible Notes Payable
Convertible Debt
[1]
Additional paid-in Capital
Warrant Issued For Vessel Consideration
[1]
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income/(loss)
Beginning balance (in shares) at Dec. 31, 2019 [1]         10,214,600                  
Beginning balance at Dec. 31, 2019 $ 481,503       $ 102 [1]     $ 918,475 [1]       $ (437,074)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income/(loss) (35,063)                     (35,063)    
Common stock issued upon vesting of restricted stock awards (in shares) [1]         65,982                  
Common stock issued upon vesting of restricted stock awards [1]         $ 1     (1)            
Common stock withheld related to net share settlement of equity awards (1,163)             (1,163) [1]            
Common stock issued from equity offerings (in shares) [1]         1,381,215                  
Common stock issued from ATM Offering, net 23,818       $ 14 [1]     23,804 [1]            
Fees for equity offerings (580)             (580) [1]            
Cash settlement of fractional shares in the Reverse Stock Split (13)             (13) [1]            
Unrealized loss on cash flow hedges (1,132)                         (1,132)
Stock-based compensation 3,048             3,048 [1]            
Ending balance (in shares) at Dec. 31, 2020 [1]         11,661,797                  
Ending balance at Dec. 31, 2020 470,418       $ 117 [1]     943,572 [1]       (472,138)   (1,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income/(loss) 184,898                     184,898    
Dividends (26,255)                     (26,255)    
Common stock issued upon vesting of restricted stock awards (in shares) [1]         81,281                  
Common stock issued upon vesting of restricted stock awards 0       $ 1 [1]     (1) [1]            
Common stock issued upon exercise of stock options (in shares) [1]         50,641                  
Common stock issued upon exercise of stock options 56       $ 1 [1]     55 [1]            
Common stock withheld related to net share settlement of equity awards (1,937)             (1,937) [1]            
Common stock issued upon conversion (in shares) [1]           25 541,898              
Common stock issued upon conversion     $ 1 $ 10,680     $ 5 [1]     $ 1 $ 10,675      
Common stock issued from equity offerings (in shares) [1]         581,385                  
Common stock issued from ATM Offering, net 27,138       $ 6 [1]     27,133 [1]            
Fees for equity offerings (233)             (233) [1]            
Unrealized loss on cash flow hedges 3,019                         3,019
Stock-based compensation 3,481             3,481 [1]            
Ending balance (in shares) at Dec. 31, 2021 [1]         12,917,027                  
Ending balance at Dec. 31, 2021 671,266 $ (12,051)     $ 129 [1]     982,746 [1] $ (20,726)     (313,495) $ 8,675 1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income/(loss) 248,009                     248,009    
Dividends (106,745)                     (106,745)    
Common stock issued upon vesting of restricted stock awards (in shares) [1]         78,598                  
Common stock issued upon vesting of restricted stock awards 0       $ 1 [1]     (1) [1]            
Common stock issued upon exercise of stock options (in shares) [1]         8,077                  
Common stock issued upon exercise of stock options 85       $ 0 [1]     85 [1]            
Common stock withheld related to net share settlement of equity awards (2,355)             (2,355) [1]            
Fees for equity offerings 201             201 [1]            
Unrealized loss on cash flow hedges 14,663                         14,663
Stock-based compensation 6,108             6,108 [1]            
Ending balance (in shares) at Dec. 31, 2022         13,003,702                  
Ending balance at Dec. 31, 2022 $ 819,181       $ 130     $ 966,058       $ (163,556)   $ 16,549
[1] * Adjusted retroactively to give effect for the 1-for-7 Reverse Stock Split that became effective as of September 15, 2020, see Note 1, General Information.